Basics Harvard Bioscience, Inc. Harvard Bioscience Inc is a developer, manufacturer and marketer of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing. IPO Date: April 1, 2001 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $21.29M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 2.54% Avg Daily Range (30 D): $0.02 | 3.32% Avg Daily Range (90 D): $0.03 | 6.85% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .48M Avg Daily Volume (90 D): 6.2M Trade Size Avg Trade Size (Sh.): 270 Avg Trade Size (Sh.) (30 D): 555 Avg Trade Size (Sh.) (90 D): 666 Institutional Trades Total Inst.Trades: 159 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $1.22M Avg Inst. Trade (90 D): $1.22M Avg Inst. Trade Volume: .43M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.84M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.22M Avg Closing Volume: 1.52M     News Aug 11, 2025 @ 11:12 AM Harvard Bioscience Tops Q2 Revenue Views Source: Jesterai Jun 2, 2025 @ 8:57 PM Harvard Bioscience Appoints John Duke to Board of ... Source: N/A May 12, 2025 @ 11:00 AM Harvard Bioscience Announces First Quarter 2025 Fi... Source: N/A Apr 10, 2025 @ 8:45 PM Harvard Bioscience Announces CFO Transition Source: N/A Mar 12, 2025 @ 8:00 PM Harvard Bioscience, Inc. to Participate in Two ... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.29 $-.05 $-1.14 Diluted EPS $-1.29 $-.05 $-1.14 Revenue $ 88.75M $ 20.45M $ 21.77M Gross Profit $ 50.49M $ 11.53M $ 12.18M Net Income / Loss $ -57.41M $ -2.28M $ -50.34M Operating Income / Loss $ -52.35M $ -.82M $ -49.67M Cost of Revenue $ 38.26M $ 8.92M $ 9.59M Net Cash Flow $ 2.42M $ 1.26M $ 1.1M PE Ratio